Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription


1 AMIA Jt Summits Transl Sci Proc
1 Arab J Urol
1 Biochim Biophys Acta
1 Biomark Med
1 Biomed Pharmacother
1 BMC Cancer
1 Bull Cancer
1 Cancer Treat Rev
1 Clin Genitourin Cancer
1 Clin Oncol (R Coll Radiol)
1 Eur J Radiol
1 Front Physiol
1 Genes Genomics
2 Int J Oncol
1 Iran J Public Health
1 J Cancer Res Ther
1 J Cell Physiol
1 J Obes
1 Lancet Oncol
1 Med Sci Monit
1 Oncotarget
1 Sci Rep
2 Urol Oncol
1 Urologe A
1 Vet J
1 Zhonghua Yi Xue Za Zhi

    AMIA Jt Summits Transl Sci Proc

  1. POIRION OB, Chaudhary K, Garmire LX
    Deep Learning data integration for better risk stratification models of bladder cancer.
    AMIA Jt Summits Transl Sci Proc. 2018;2017:197-206.
    >> Share

    Arab J Urol

  2. MAZDAK H, Tolou-Ghamari Z
    Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran.
    Arab J Urol. 2018;16:206-210.
    >> Share

    Biochim Biophys Acta

  3. WEN H, Lee S, Zhu WG, Lee OJ, et al
    Glucose-derived acetate and ACSS2 as key players in cisplatin resistance in bladder cancer.
    Biochim Biophys Acta. 2018 Jun 5. pii: S1388-1981(18)30126.
    >> Share

    Biomark Med

  4. TOLLE A, Blobel CC, Jung K
    Circulating miRNAs in blood and urine as diagnostic and prognostic biomarkers for bladder cancer: an update in 2017.
    Biomark Med. 2018 Jun 13. doi: 10.2217/bmm-2017-0392.
    >> Share

    Biomed Pharmacother

  5. LI Z, Lin C, Zhao L, Zhou L, et al
    Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Biomed Pharmacother. 2018;105:461-469.
    >> Share

    BMC Cancer

  6. LIU Y, Wang H, Zhong J, Wu C, et al
    Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis.
    BMC Cancer. 2018;18:642.
    >> Share

    Bull Cancer

  7. MARINONI F, Destro F, Selvaggio GGO, Riccipetitoni G, et al
    Urothelial carcinoma in children: A case series.
    Bull Cancer. 2018;105:556-561.
    >> Share

    Cancer Treat Rev

  8. TAN WS, Tan WP, Tan MY, Khetrapal P, et al
    Novel urinary biomarkers for the detection of bladder cancer: A systematic review.
    Cancer Treat Rev. 2018;69:39-52.
    >> Share

    Clin Genitourin Cancer

  9. BOSSCHIETER J, Hentschel A, Savci-Heijink CD, Patrick van der Voorn J, et al
    Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Non-muscle-invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors.
    Clin Genitourin Cancer. 2018 May 11. pii: S1558-7673(18)30196.
    >> Share

    Clin Oncol (R Coll Radiol)

  10. JENA R
    Bladder Cancer Virtual Special Issue.
    Clin Oncol (R Coll Radiol). 2018 Jun 5. pii: S0936-6555(18)30276.
    >> Share

    Eur J Radiol

  11. HARTMAN R, Kawashima A
    Lower tract neoplasm: Update of imaging evaluation.
    Eur J Radiol. 2017 Nov 1. pii: S0720-048X(17)30415.
    >> Share

    Front Physiol

  12. SU G, He Q, Wang J
    Clinical Values of Long Non-coding RNAs in Bladder Cancer: A Systematic Review.
    Front Physiol. 2018;9:652.
    >> Share

    Genes Genomics

  13. YANG J, Li W, Zhang Z, Shen J, et al
    PSCArs2294008 T polymorphism increases the risk of bladder cancer in Bai, Dai, and Han ethnicity in China and a potential mechanism.
    Genes Genomics. 2018;40:531-541.
    >> Share

    Int J Oncol

  14. ZHANG L, Yang G, Zhang R, Dong L, et al
    Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells.
    Int J Oncol. 2018 May 30. doi: 10.3892/ijo.2018.4423.
    >> Share

  15. SUGITA S, Enokida H, Yoshino H, Miyamoto K, et al
    HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
    Int J Oncol. 2018 Jun 11. doi: 10.3892/ijo.2018.4435.
    >> Share

    Iran J Public Health

  16. RASHIDIAN H, Zendehdel K, Daroudi R, Ebadzadeh MR, et al
    Epidemiology and Hospitalization Cost of Bladder Cancer in Kerman Province, Southeastern Iran.
    Iran J Public Health. 2018;47:567-574.
    >> Share

    J Cancer Res Ther

  17. RAFIEMANESH H, Lotfi Z, Bakhtazad S, Ghoncheh M, et al
    The epidemiological and histological trend of bladder cancer in Iran.
    J Cancer Res Ther. 2018;14:532-536.
    >> Share

    J Cell Physiol

  18. ZO RB, Long Z
    MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B.
    J Cell Physiol. 2018 Jun 12. doi: 10.1002/jcp.26591.
    >> Share

    J Obes

  19. HARIHARAN N, Ashcraft KA, Svatek RS, Livi CB, et al
    Adipose Tissue-Secreted Factors Alter Bladder Cancer Cell Migration.
    J Obes. 2018;2018:9247864.
    >> Share

    Lancet Oncol

  20. GOURD E
    EMA restricts use of anti-PD-1 drugs for bladder cancer.
    Lancet Oncol. 2018 Jun 7. pii: S1470-2045(18)30433.
    >> Share

    Med Sci Monit

  21. WANG Z, Li H, Chi Q, Qiu Y, et al
    Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer.
    Med Sci Monit. 2018;24:3882-3887.
    >> Share


  22. RINALDETTI S, Rempel E, Worst TS, Eckstein M, et al
    Subclassification, survival prediction and drug target analyses of chemotherapy-naive muscle-invasive bladder cancer with a molecular screening.
    Oncotarget. 2018;9:25935-25945.
    >> Share

    Sci Rep

  23. CHEN Y, Li W, Zeng Z, Tang Y, et al
    (-)-Gochnatiolide B, synthesized from dehydrocostuslactone, exhibits potent anti-bladder cancer activity in vitro and in vivo.
    Sci Rep. 2018;8:8807.
    >> Share

    Urol Oncol

  24. FRANSEN VAN DE PUTTE EE, Otto W, Hartmann A, Bertz S, et al
    Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer.
    Urol Oncol. 2018 Jun 4. pii: S1078-1439(18)30159.
    >> Share

  25. VARTOLOMEI MD, Porav-Hodade D, Ferro M, Mathieu R, et al
    Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis.
    Urol Oncol. 2018 Jun 5. pii: S1078-1439(18)30166.
    >> Share

    Urologe A

  26. RETZ M, Karl A
    [Bladder cancer : Current diagnosis and treatment modalities].
    Urologe A. 2018;57:655-656.
    >> Share

    Vet J

  27. HONKISZ SI, Naughton JF, Weng HY, Fourez LM, et al
    Evaluation of two-dimensional ultrasonography and computed tomography in the mapping and measuring of canine urinary bladder tumors.
    Vet J. 2018;232:23-26.
    >> Share

    Zhonghua Yi Xue Za Zhi

  28. WANG JF, Zhou XF, Fang DB, Wu ZM, et al
    [The effect of tri-modality therapy on the treatment of muscle-invasive bladder cancer].
    Zhonghua Yi Xue Za Zhi. 2018;98:1614-1616.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016